Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

STRIDES PHARMA SCIENCE LTD.

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private

BSE1503.750.65 (+0.04 %)

PREV CLOSE ( ) 1503.10

OPEN PRICE ( ) 1523.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 7482

TODAY'S LOW / HIGH ( )1487.05 1539.80

52 WK LOW / HIGH ( )482.5 1675.25

NSE1504.250.6 (+0.04 %)

PREV CLOSE( ) 1503.65

OPEN PRICE ( ) 1503.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1504.25 (6)

VOLUME 193884

TODAY'S LOW / HIGH( ) 1487.20 1540.00

52 WK LOW / HIGH ( )482 1675

Quarters

Select year

( in Million)

Particulars

Sep 2024

Jun 2024

Mar 2024

Dec 2023

Audited / UnAudited

UnAudited

Net Sales

12011.1

10875.05

10840.35

10376.68

Total Expenditure

9653.03

8705.24

8543.01

8438.57

PBIDT (Excl OI)

2358.07

2169.81

2297.34

1938.11

Other Income

284.11

127.16

-135.46

87.54

Operating Profit

2642.18

2296.97

2161.88

2025.65

Interest

821.49

803.89

801.56

792.84

Exceptional Items

-38.72

-37.37

-80.71

-100.67

PBDT

1781.97

1455.71

1279.61

1132.14

Depreciation

505.24

485.94

497.6

512.28

Profit Before Tax

1276.73

969.77

782.00

619.85

Tax

212.03

168.61

192.51

101.02

Provisions and contingencies

Profit After Tax

1064.7

801.16

589.49

518.83

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

1064.7

801.16

590.21

1060.32

Minority Interest

-4.29

18.9

77.32

-43.91

Shares of Associates

-128.09

-118.04

-485.79

-519.74

Other related items

Misc. Expenses Written off

Consolidated Net Profit

932.32

702.02

181.75

496.67

Equity Capital

919.58

919.17

919

918.85

Face Value (IN RS)

Reserves

Calculated EPS

10.13

7.63

1.97

5.40

Calculated EPS (Annualised)

40.55

30.55

7.91

21.62

No of Public Share Holdings

68196887

68149172

68118171

66713852

% of Public Share Holdings

74.16

74.14

74.12

72.61

PBIDTM% (Excl OI)

19.63

19.95

21.19

18.67

PBIDTM%

21.99

21.12

19.94

19.52

PBDTM%

14.83

13.38

11.80

10.91

PBTM%

10.62

8.91

7.21

5.97

PATM%

8.86

7.36

5.43

5.00

Notes

Risk Disclosures on Derivatives

Quarterly Results

STRIDES PHARMA SCIENCE LTD.